Skip to Content

Clinical Trials Details

OMB 113676

Patient Information

OMB 113676 - Phase III Randomized, Open Label Study of Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy

View more information about clinical trial - OMB 113676

Study Number
OMB 113676

Clinical Trial Categories

  • Lymphoma


  • Cone Health Cancer Center at Wesley Long
    501 N. Elam Avenue
    Greensboro, NC 27403
    Main: 336-832-1100

Also in this Section